Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

Investor Overview

Investor Overview

Corporate Citizenship Report

Corporate Citizenship Report

Charles River is committed to environmental, social, and governance (ESG) transparency. We are pleased to present our first Corporate Citizenship Report, which includes a GRI Content Index and ESG performance data table.

Upcoming Events
There are currently no events scheduled.

Featured Report

2019 Annual Report (PDF)

Charles River Corporate Citizenship Report
View PDF
Print PDF